Allergan, Inc. (AGN) Misses Q1 EPS by 1c; Guides Q2 EPS, Revs Below Views
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Total non-operating income (expense): 26.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total non-operating income (expense): 26.6M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Allergan, Inc. (NYSE: AGN) reported Q1 EPS of $0.86, $0.01 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $1.37 million versus the consensus estimate of $1.38 million.
Allergan, Inc. sees Q2 2012 EPS of $1.04-$1.06, versus the consensus of $1.09. Allergan, Inc. sees Q2 2012 revenue of $1.45-$1.50 billion, versus the consensus of $1.51 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Allergan, Inc. sees Q2 2012 EPS of $1.04-$1.06, versus the consensus of $1.09. Allergan, Inc. sees Q2 2012 revenue of $1.45-$1.50 billion, versus the consensus of $1.51 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
